BCL2 and hepatocellular carcinoma: Similarly, APS can accelerate apoptosis in HepG2 HCC cells by decreasing Bcl-2, β-catenin, c-Myc, and Cyclin D1, which may be related to the Wnt/β-catenin signaling pathway [76].